Request for Covid-19 Impact Assessment of this Report

Take Action
Diagnostic and Biotech

Global Soft Tissue Allografts Market Size study, by Type (Cartilage Allograft, Tendon Allograft, Meniscus Allograft, Dental Allograft, Others), by Application (Orthopedic, Dentistry, Wound Care, Others), by End-User (Hospitals, Aesthetic Centers, Orthopedic Clinics, Dental Clinics, Others) and Regional Forecasts 2020-2026

  • BIZ3834151
  • 200 Pages
  • April 2020
  • Diagnostic and Biotech
Download Sample    Get Discount   
 
Global Soft Tissue Allografts Market is valued approximately USD 4.0 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 7.0% over the forecast period 2020-2026. Soft tissue allografts are a type of substitute tissues used in reconstruction of deficient ligaments, torn menisci, spinal surgeries and osteochondral defects during knee surgeries. Soft tissue allografts have required to undergo a safety screening process in three stages that include donor screening, laboratory testing, and tissue preparation. The use of these allografts has a latent for disease transmission, delayed graft incorporation and host versus donor immunologic reaction to the graft. Further, these allografts are majorly made up of skin, tendons, veins, cartilage and heart valves, and are used for transplant in distinct forms of surgeries. Rise in the incidences of degenerative joint disorders, growing number of the elderly population and escalating demand for soft tissue allografts among athletic patients are the few factors responsible for high CAGR of the market over the forecast period. As per the report published by the Transplant Department of Cleveland Clinic, there were around 30,000 surgeries with allograft tissue are performed every year in the clinics including, meniscal transplants and anterior cruciate ligament procedures. Similarly, as per the World Health Organization (WHO), degenerative joint diseases affect 18.0% women and 9.6% men aged above 60 years with symptomatic osteoarthritis. This, in turn, is expected to accelerate the demand for soft tissue allografts, thus contributing to the growth of the global market. However, thehigh cost of the treatment, aided with unfavorable reimbursement policies are the few factors expected to hamper the growth of the market over the forecast period of 2020-2026.

The regional analysis of global Soft Tissue Allografts market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the surging prevalence of diabetic foot ulcers, presence of healthcare awareness program for diseases and rise in number of surgical procedures on anterior cruciate ligament (ACL) in the region. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2026, due to increase in number of tissue banks and growing aging population in the countries like China and India.

Major market player included in this report are:

Allergan Plc

B. Braun Melsungen AG

CONMED Corporation

Xtant Medical Holdings, Inc.

Alliqua BioMedical, Inc.

AlonSource Group

Becton Dickinson and Company

Arthrex, Inc.

Bone Bank Allografts

Integra LifeSciences Corporation

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

Cartilage Allograft

Tendon Allograft

Meniscus Allograft

Dental Allograft

Others

By Application:

Orthopedic

Dentistry

Wound Care

Others

By End-User:

Hospitals

Aesthetic Centers

Orthopedic Clinics

Dental Clinics

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

Asia Pacific

China

India

Japan

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2016, 2017, 2018

Base year – 2019

Forecast period – 2020 to 2026

Target Audience of the Global Soft Tissue Allografts Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Chapter 1. Executive Summary

1.1. Market Snapshot

1.2. Global & Segmental Market Estimates & Forecasts, 2018-2026 (USD Billion)

1.2.1. Soft Tissue Allografts Market, by Region, 2018-2026 (USD Billion)

1.2.2. Soft Tissue Allografts Market, by Type, 2018-2026 (USD Billion)

1.2.3. Soft Tissue Allografts Market, by Application, 2018-2026 (USD Billion)

1.2.4. Soft Tissue Allografts Market, by End-User, 2018-2026 (USD Billion)

1.3. Key Trends

1.4. Estimation Methodology

1.5. Research Assumption

Chapter 2. Global Soft Tissue Allografts Market Definition and Scope

2.1. Objective of the Study

2.2. Market Definition & Scope

2.2.1. Scope of the Study

2.2.2. Industry Evolution

2.3. Years Considered for the Study

2.4. Currency Conversion Rates

Chapter 3. Global Soft Tissue Allografts Market Dynamics

3.1. Soft Tissue Allografts Market Impact Analysis (2018-2026)

3.1.1. Market Drivers

3.1.2. Market Challenges

3.1.3. Market Opportunities

Chapter 4. Global Soft Tissue Allografts Market Industry Analysis

4.1. Porter’s 5 Force Model

4.1.1. Bargaining Power of Suppliers

4.1.2. Bargaining Power of Buyers

4.1.3. Threat of New Entrants

4.1.4. Threat of Substitutes

4.1.5. Competitive Rivalry

4.1.6. Futuristic Approach to Porter’s 5 Force Model (2016-2026)

4.2. PEST Analysis

4.2.1. Political

4.2.2. Economical

4.2.3. Social

4.2.4. Technological

4.3. Investment Adoption Model

4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Soft Tissue Allografts Market, by Type

5.1. Market Snapshot

5.2. Global Soft Tissue Allografts Market by Type, Performance - Potential Analysis

5.3. Global Soft Tissue Allografts Market Estimates & Forecasts by Type 2016-2026 (USD Billion)

5.4. Soft Tissue Allografts Market, Sub Segment Analysis

5.4.1. Cartilage Allograft

5.4.2. Tendon Allograft

5.4.3. Meniscus Allograft

5.4.4. Dental Allograft

5.4.5. Others

Chapter 6. Global Soft Tissue Allografts Market, by Application

6.1. Market Snapshot

6.2. Global Soft Tissue Allografts Market by Application, Performance - Potential Analysis

6.3. Global Soft Tissue Allografts Market Estimates & Forecasts by Application 2016-2026 (USD Billion)

6.4. Soft Tissue Allografts Market, Sub Segment Analysis

6.4.1. Orthopedic

6.4.2. Dentistry

6.4.3. Wound Care

6.4.4. Others

Chapter 7. Global Soft Tissue Allografts Market, by End-User

7.1. Market Snapshot

7.2. Global Soft Tissue Allografts Market by End-User, Performance - Potential Analysis

7.3. Global Soft Tissue Allografts Market Estimates & Forecasts by End-User 2016-2026 (USD Billion)

7.4. Soft Tissue Allografts Market, Sub Segment Analysis

7.4.1. Hospitals

7.4.2. Aesthetic Centers

7.4.3. Orthopedic Clinics

7.4.4. Dental Clinics

7.4.5. Others

Chapter 8. Global Soft Tissue Allografts Market, Regional Analysis

8.1. Soft Tissue Allografts Market, Regional Market Snapshot

8.2. North America Soft Tissue Allografts Market

8.2.1. U.S. Soft Tissue Allografts Market

8.2.1.1. Type breakdown estimates & forecasts, 2016-2026

8.2.1.2. Application breakdown estimates & forecasts, 2016-2026

8.2.1.3. End-User breakdown estimates & forecasts, 2016-2026

8.2.2. Canada Soft Tissue Allografts Market

8.3. Europe Soft Tissue Allografts Market Snapshot

8.3.1. U.K. Soft Tissue Allografts Market

8.3.2. Germany Soft Tissue Allografts Market

8.3.3. Rest of Europe Soft Tissue Allografts Market

8.4. Asia-Pacific Soft Tissue Allografts Market Snapshot

8.4.1. China Soft Tissue Allografts Market

8.4.2. India Soft Tissue Allografts Market

8.4.3. Japan Soft Tissue Allografts Market

8.4.4. Rest of Asia Pacific Soft Tissue Allografts Market

8.5. Latin America Soft Tissue Allografts Market Snapshot

8.5.1. Brazil Soft Tissue Allografts Market

8.5.2. Mexico Soft Tissue Allografts Market

8.6. Rest of The World Soft Tissue Allografts Market

Chapter 9. Competitive Intelligence

9.1. Top Market Strategies

9.2. Company Profiles

9.2.1. Allergan Plc

9.2.1.1. Key Information

9.2.1.2. Overview

9.2.1.3. Financial (Subject to Data Availability)

9.2.1.4. Type Summary

9.2.1.5. Recent Developments

9.2.2. B. Braun Melsungen AG

9.2.3. CONMED Corporation

9.2.4. Xtant Medical Holdings, Inc.

9.2.5. Alliqua BioMedical, Inc.

9.2.6. AlonSource Group

9.2.7. Becton Dickinson and Company

9.2.8. Arthrex, Inc.

9.2.9. Bone Bank Allografts

9.2.10. Integra LifeSciences Corporation

Chapter 10. Research Process

10.1. Research Process

10.1.1. Data Mining

10.1.2. Analysis

10.1.3. Market Estimation

10.1.4. Validation

10.1.5. Publishing

10.2. Research Attributes

10.3. Research Assumption

List of Tables

TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL SOFT TISSUE ALLOGRAFTS MARKET

TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL SOFT TISSUE ALLOGRAFTS MARKET

TABLE 3. GLOBAL SOFT TISSUE ALLOGRAFTS MARKET, REPORT SCOPE

TABLE 4. YEARS CONSIDERED FOR THE STUDY

TABLE 5. EXCHANGE RATES CONSIDERED

TABLE 6. GLOBAL SOFT TISSUE ALLOGRAFTS MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD BILLION)

TABLE 7. GLOBAL SOFT TISSUE ALLOGRAFTS MARKET ESTIMATES & FORECASTS BY TYPE 2016-2026 (USD BILLION)

TABLE 8. GLOBAL SOFT TISSUE ALLOGRAFTS MARKET ESTIMATES & FORECASTS BY APPLICATION 2016-2026 (USD BILLION)

TABLE 9. GLOBAL SOFT TISSUE ALLOGRAFTS MARKET ESTIMATES & FORECASTS BY END-USER 2016-2026 (USD BILLION)

TABLE 10. GLOBAL SOFT TISSUE ALLOGRAFTS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 11. GLOBAL SOFT TISSUE ALLOGRAFTS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 12. GLOBAL SOFT TISSUE ALLOGRAFTS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 13. GLOBAL SOFT TISSUE ALLOGRAFTS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 14. GLOBAL SOFT TISSUE ALLOGRAFTS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 15. GLOBAL SOFT TISSUE ALLOGRAFTS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 16. GLOBAL SOFT TISSUE ALLOGRAFTS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 17. GLOBAL SOFT TISSUE ALLOGRAFTS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 18. GLOBAL SOFT TISSUE ALLOGRAFTS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 19. GLOBAL SOFT TISSUE ALLOGRAFTS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 20. U.S. SOFT TISSUE ALLOGRAFTS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 21. U.S. SOFT TISSUE ALLOGRAFTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 22. U.S. SOFT TISSUE ALLOGRAFTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 23. CANADA SOFT TISSUE ALLOGRAFTS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 24. CANADA SOFT TISSUE ALLOGRAFTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 25. CANADA SOFT TISSUE ALLOGRAFTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 26. UK SOFT TISSUE ALLOGRAFTS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 27. UK SOFT TISSUE ALLOGRAFTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 28. UK SOFT TISSUE ALLOGRAFTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 29. GERMANY SOFT TISSUE ALLOGRAFTS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 30. GERMANY SOFT TISSUE ALLOGRAFTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 31. GERMANY SOFT TISSUE ALLOGRAFTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 32. ROE SOFT TISSUE ALLOGRAFTS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 33. ROE SOFT TISSUE ALLOGRAFTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 34. ROE SOFT TISSUE ALLOGRAFTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 35. CHINA SOFT TISSUE ALLOGRAFTS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 36. CHINA SOFT TISSUE ALLOGRAFTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 37. CHINA SOFT TISSUE ALLOGRAFTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 38. INDIA SOFT TISSUE ALLOGRAFTS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 39. INDIA SOFT TISSUE ALLOGRAFTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 40. INDIA SOFT TISSUE ALLOGRAFTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 41. JAPAN SOFT TISSUE ALLOGRAFTS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 42. JAPAN SOFT TISSUE ALLOGRAFTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 43. JAPAN SOFT TISSUE ALLOGRAFTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 44. ROAPAC SOFT TISSUE ALLOGRAFTS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 45. ROAPAC SOFT TISSUE ALLOGRAFTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 46. ROAPAC SOFT TISSUE ALLOGRAFTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 47. BRAZIL SOFT TISSUE ALLOGRAFTS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 48. BRAZIL SOFT TISSUE ALLOGRAFTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 49. BRAZIL SOFT TISSUE ALLOGRAFTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 50. MEXICO SOFT TISSUE ALLOGRAFTS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 51. MEXICO SOFT TISSUE ALLOGRAFTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 52. MEXICO SOFT TISSUE ALLOGRAFTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 53. ROLA SOFT TISSUE ALLOGRAFTS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 54. ROLA SOFT TISSUE ALLOGRAFTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 55. ROLA SOFT TISSUE ALLOGRAFTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 56. ROW SOFT TISSUE ALLOGRAFTS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 57. ROW SOFT TISSUE ALLOGRAFTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 58. ROW SOFT TISSUE ALLOGRAFTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Biomaterials Market by Type (Metallic, Polymeric, Ceramic and Natural) and Application (Cardiovascular, Dental, Orthopedic, Wound Healing, Plastic, Surgery, Ophthalmology, Tissue Engineering, Neurological Disorders and Drug-Delivery Systems) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022

Biomaterials are materials of either synthetic or natural origin that are used for interaction with biological systems for medical purposes such as treating or repairing damage tissues. They are used in joint replacements, plastic surgeries, drug delivery devi...

  • Publish Date: September 1, 2016
  • $5370
View Details
DNA Sequencing Market by Product (Consumable, Instrument, and Service) Application (Biomarkers and Cancer, Diagnostics, Reproductive Health, Personalized Medicine, Forensics, and Others), Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Pyrosequencing, Single Molecule Real-time Sequencing, Chain Termination Sequencing, and Nanopore Sequencing), and End User (Academic & Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, and Hospitals & Clinics): Global Opportunity Analysis and Industry Forecast, 2017 - 2025

The global DNA sequencing market was estimated to be $6,243 million in 2017 and is projected to reach $25,470 million in 2025 growing with a CAGR of 19% from 2018 to 2025. DNA sequencing is a type of technology in which several DNA strands can be sequenced through massive parallelization. The DNA sequencing contains both Sanger’s method of sequencing and non-Sanger’s methods of sequencing. ...

  • Publish Date: May 24, 2017
  • $5370
View Details
Nerve Repair and Regeneration Market by Surgery [Direct Neuropathy by Type (Epineural Repair, Perineural Repair, and Group Fascicular Repair), Nerve Grafting by Type (Autografts, Allografts, and Xenografts), Neuromodulation Surgery (External and Internal), and Stem Cell Therapy] and Product [Biomaterial by Type (Nerve Conduits, Nerve Protectors, Nerve Wraps, and Nerve Connectors) and Neuromodulation Surgery Devices by Type (External by Type (Transcutaneous Electrical Nerve Stimulation and Transcranial Magnetic Stimulation) and Internal by Type (Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, and Others)]: Global Opportunity Analysis and Industry Forecast, 2017-2023

Patients with serious nervous system injuries or strokes often require lifelong assistance, which burdens patients, their families, and society. Innovative, paradigm shifting strategies are required to develop treatments for neurological injury. Early dia...

  • Publish Date: May 24, 2017
  • $5370
View Details
 
View More
 

Client Testimonials

2025 © Copyright Big Market Research